Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @1ABMedia
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @1ABMedia
-
Prikvačeni tweet
Our team is so incredibly proud to have worked with Alexis, Melanie, Sue and the team to launch this ambitious new company. Introducing EQRx.
#JPM20https://twitter.com/DanBudwick/status/1216386341652447232 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
VIDEO: Dr. John DiPersio discusses initial Ph 1 results, demonstrating MGTA-145, combined w/ plerixafor, enables safe, same-day dosing, mobilization & collection of sufficient high-quality HSCs for transplant - more to come at
#TCTM20 in Feb! https://vjhemonc.com/video/li8n6i7ik34-mgta-145-with-plerixafor-induces-rapid-mobilization-of-cd34-hscs/ …@VJHemOncHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
.
@US_FDA announces guidance to provide regulatory clarity for gene therapy developershttps://twitter.com/SteveFDA/status/1222152149502775296 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
Alector
$ALEC announces Phase 1b initiation of AL003 in people living with Alzheimer's disease. Alector has developed AL003 to block the inhibitory function of SIGLEC 3, an immune receptor linked to AD https://investors.alector.com/node/7011/pdfHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
Section 32 founder
@billmaris &@ThirdRockV COO@kgtrv discuss the biopharma industry’s prep for the upcoming election w/@barronsonline@joshnathankazis#JPM20https://twitter.com/barronsonline/status/1218303098285907968 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The last of our
#JPM20 video series, with thanks to our incredible team for their outstanding work at the conference...and to all of you for tuning into these videos! Hope you enjoyed them!pic.twitter.com/tqQlYHYst4Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
Alector
$ALEC CEO Arnon Rosenthal discusses its immuno-neurology approach and key pipeline catalysts for 2020 at#JPM20pic.twitter.com/LtqLKnnuzP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
.
@MagentaTx$MGTA CEO @jasonbiotech1 kicks off the co’s presentation with an MS patient case, discusses transplant medicine and the role its pipeline can play in expanding access at#JPM20pic.twitter.com/9QzKJvaaJ8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What is your best tv, book or podcast recommendation? In the final question of our video series, we asked our clients and friends what they are enjoying when they aren’t at
#JPM20.pic.twitter.com/tQBGsy5egtHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited to hear
@insitro@DaphneKoller &@EQRxINC@MNallicheri at#JPM20@FierceBiotech event!https://twitter.com/DanBudwick/status/1217144270932471809 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kicking off Day 2 of
#JPM20 by asking what trends our friends and clients are watching for in 2020. Leave yours below!pic.twitter.com/BR97DMLMfmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
.
@moderna_tx$MRNA CEO @sbancel discusses pipeline execution in 2019 and upcoming milestones to watch at#JPM20pic.twitter.com/D6NqIOamSC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
SRO and well out the doors to see Verily and CEO Andy Conrad’s first-ever presentation at
#JPM20pic.twitter.com/Zhri5LrpQs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
A lot of interest in
@Relay_Tx’s precision medicine approach as CEO@SanjivKPatel1 addresses the masses at#JPM20pic.twitter.com/sLJoJBIG1C
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Rise and shine,
#JPM20 is finally here! We are awake with coffee in hand. In our sixth video, we asked our clients and friends, how they start their mornings at JPM, including@c_lengauer and@gobluebird1's dedication to... working out?!pic.twitter.com/8cwzn0YfDFHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
.
@AgiosPharma$AGIO CEO Jackie Fouse discusses the depth of the co’s pipeline and upcoming milestones in 2020 at#JPM20pic.twitter.com/uGK3tX2P0o
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
Loxo Oncology at Lilly’s
$LLY@joshbilenker &@moderna_tx$MRNA CEO@sbancel discuss R&D collaborations and M&A at@endpts breakfast event.#JPM20pic.twitter.com/I7wU2UIn3f
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Where do all the mattresses go?
@katie_engleman and@DanBudwick answer (and get it wrong) this and other#JPM20-related questions from@FierceBiotech@amirahalidrushttps://www.fiercebiotech.com/biotech/no-sleep-exiled-mattresses-cleared-bank-accounts-getting-deals-done-at-jpm …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1AB proslijedio/la je Tweet
The
@1ABMedia team has had an amazing start to#JPM20 - so proud of this incredibly talented team!pic.twitter.com/L86xHHiKj1 – mjesto: Park TavernHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Do you prefer the early mornings or the long nights of
#JPM20? Maybe you’re like the#1AB team and you are both! In the fifth video of our series, hear who is a morning person and who is a night person.pic.twitter.com/mZYrsnJw3XHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.